The Microcystic, Elongated, and Fragmented (MELF) Pattern of Invasion
- 1 January 2017
- journal article
- research article
- Published by Wolters Kluwer Health in American Journal of Surgical Pathology
- Vol. 41 (1) , 49-55
Abstract
MELF invasion has been associated with nonvaginal recurrences and lymph node (LN) metastases in multi-institutional case control studies but has not been well examined in large single-institution cohorts. Hysterectomy specimens with FIGO 1 endometrioid endometrial carcinoma and lymphadenectomies from 2007 to 2012 were identified. Electronic medical records and histologic slides were reviewed. Of 464 identified cases, 163 (35.1%) were noninvasive, 60 (12.9%) had MELF, 222 (47.8%) had a component of the infiltrative invasion pattern without MELF, 13 (2.8%) had pure pushing borders of invasion, 5 (1.1%) had pure adenomyosis-like invasion, and 1 (0.2%) had pure adenoma malignum-like invasion. Sixteen cases had LN metastases. Significantly more MELF cases had positive LNs than non-MELF cases overall (18.3% vs. 1.2%, PPP=0.137. A majority of positive LNs, even in MELF cases, demonstrated nonhistiocyte-like metastases. Only 5 cases (all with MELF invasion) demonstrated micrometastatic lesions or isolated tumor cells only. MELF cases demonstrated a nonsignificant decrease in time to extravaginal recurrence (P=0.082, log-rank test), for which analysis was limited by low recurrence rates. In summary, MELF is associated with LN metastases, even when compared with other infiltrative cases and shows multiple patterns of growth in positive LNs. MELF cases additionally trended toward decreased time to extravaginal recurrence.Keywords
This publication has 27 references indexed in Scilit:
- The association of the microcystic, elongated and fragmented (MELF) invasion pattern in endometrial carcinomas with deep myometrial invasion, lymphovascular space invasion and lymph node metastasisJournal of Obstetrics and Gynaecology, 2014
- Risk Factors for Recurrence and Prognosis of Low-grade Endometrial Adenocarcinoma; Vaginal Versus Other SitesInternational Journal of Gynecological Pathology, 2014
- Low-grade, Low-stage Endometrioid Endometrial AdenocarcinomaInternational Journal of Gynecological Pathology, 2012
- Obesity in relation to endometrial cancer risk and disease characteristics in the Women's Health InitiativeGynecologic Oncology, 2011
- CD147 (EMMPRIN) and matrix metalloproteinase-2 expression in uterine endometrioid adenocarcinomaPathology - Research and Practice, 2011
- Galectin-3 Expression in Uterine Endometrioid AdenocarcinomaInternational Journal of Gynecological Pathology, 2010
- Epithelial-Mesenchymal Transitions in Development and DiseaseCell, 2009
- The outcomes of 27,063 women with unstaged endometrioid uterine cancerGynecologic Oncology, 2007
- Endometrioid Carcinoma of the Uterine Corpus: A Review of Its Pathology With Emphasis on Recent Advances and Problematic AspectsAdvances in Anatomic Pathology, 2002
- Traditional and Nontraditional Histopathologic Predictors of Recurrence in Uterine Endometrioid AdenocarcinomaGynecologic Oncology, 1994